500 Participants Needed

Cefepime Dosing for Infections

GW
Overseen ByGerald W. Flaby Jr., LRT, RRT
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this study is to compare two different ways of dosing cefepime, an antibiotic for very sick patients - the usual approach to dosing or a new dosing method. The new dosing method uses only doses that are available in normal care, but choosing between the different doses is based on more information about the patient's body including their kidney function. The primary purpose of this study is to test how easy it is for healthcare professionals to use the new dosing method and how best to conduct the trial. The study will also assess if the new dosing method helps patients recover faster and reduces side effects.

Who Is on the Research Team?

EB

Erin Barreto, PharmD, PhD

Principal Investigator

Mayo Clinic

Are You a Good Fit for This Trial?

This trial is for very sick patients with severe bacterial skin infections or sepsis, which is a dangerous body response to infection. Participants must have certain conditions like acute bacterial skin and skin structure infections or septic shock. The study excludes specific details not provided.

Inclusion Criteria

Admitted to one of the ICUs at the study center
I am prescribed cefepime by my doctor.
I am 18 years old or older.

Exclusion Criteria

Declined Minnesota research authorization
Individuals with a cephalosporin allergy
I was given cefepime before being admitted to the ICU.
See 8 more

What Are the Treatments Tested in This Trial?

Interventions

  • Cefepime

Trial Overview

The BLOOM trial compares usual antibiotic dosing with a new individualized method based on patient information such as kidney function. It aims to see if healthcare professionals can easily use the new method and how it affects patient recovery and side effects.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Up-front individualized dosing algorithmExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+